There was an overall trend of decreased susceptibility to beta-lactams in this cohort when compared with fluoroquinolones and SMX-TMP.
← all excerpts
Assessment of treatment outcomes in patients receiving high- versus low-dose sulfamethoxazole-trimethoprim for oral stepdown therapy in gram-negative bacteremia: a multi-center, retrospective cohort study.
1
—
—